Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Mol Immunol. 2008 Mar 4;45(9):2429–2436. doi: 10.1016/j.molimm.2008.01.002

Table 4.

Association of Class II HLA alleles with Chronic Viremia and Spontaneous Clearance

Class II Allele SC N= 39 CV N=121
N (%) n (%) OR (CI) p value
HLA-DQB1*0501 3 (7.7) 26 (22.3) 0.30 (0.07–1.15) 0.05
HLA-DRB1*0101 4 (10.2) 21 (17.3) 0.52 (0.15–1.84) 0.24
HLA-DQB1*0501 + HLA-DRB1*0101 3 (7.7) 14 (10.7) 0.64 (0.14–2.56) 0.49
HLA-DRB1*1101 4 (10.2) 29 (23.9) 0.36 (0.36–1.19) 0.07
HLA-DQB1*0301 16 (41.0) 43 (34.7) 1.27 (0.56–2.81) 0.53
HLA-DRB1*1101 + HLA-DQB1*0301 3 (7.7) 21 (18.2) 0.40 (0.40–1.52) 0.19
HLA-DRB1*1201 6 (15.4) 3 (0.8) 7.15 (1.48–38.52) 0.007
HLA-DRB1*1201 + HLA-DQB1*0301 4 (10.25) 0 13.71 (ND) 0.003

SC: Spontaneous clearance; CV chronic viremia; OR: Odds Ratio; CI: 95% Confidence Interval; ND: not determined because CI is not accurate.

HHS Vulnerability Disclosure